TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO. Share Price

Certificat

DE000SD4MA35

Real-time Boerse Frankfurt Warrants 12:30:25 03/06/2024 BST
4.86 EUR +0.41% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO.
1 month-9.53%
3 months-7.10%
Date Price Change
03/06/24 4.86 +0.41%
31/05/24 4.84 +0.21%
30/05/24 4.83 -2.42%
29/05/24 4.95 +0.81%
28/05/24 4.91 -4.84%

Real-time Boerse Frankfurt Warrants

Last update June 03, 2024 at 12:30 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SD4MA3
ISINDE000SD4MA35
Date issued 12/03/2021
Strike 72.95 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.86
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.61
Lowest since issue 0.63
Spread 0.06
Spread %1.22%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5 USD
Average target price
141.9 USD
Spread / Average Target
+13.01%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW